At PSYCH Symposium in the British Museum on 6 July, the panel ‘Neuroimaging & Psychedelics: The Past, Present & Future’ explored how neuroimaging can inform our...
PSYCH Symposium’s afternoon panels saw discussions continue the exploration of the landscape of psychedelic healthcare.
PSYCH Symposium returned at the British Museum on 6 July to explore how psychedelic medicines can innovate healthcare – from mental health to eating disorders and...
PSYCH Symposium is returning at the British Museum on 6 July, when a panel of experts will discuss how psychedelics could innovate eating disorder care.
The high of MDMA (a.k.a.
Psychedelics stand at a pivotal crossroads in mental health, offering the prospect of novel therapeutic avenues to address multiple mental conditions, from treatment-resistant depression to post-traumatic...
PSYCH Symposium is returning at the British Museum on 6 July, when a panel of changemakers and MEPs will discuss the future of psychedelic healthcare in...
Alexander Shulgin, best known for introducing MDMA to the psychological community, also created over 230 novel psychoactive compounds and documented their effects in the book PiHKAL:...
A new report estimates that more than four million people in the Americas, Europe, Australia, and New Zealand have consumed ayahuasca at some point in their...
The use of psychedelics in research has a long and storied history, dating back to the mid-20th century.